You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
The company will receive an upfront $9.3 million to fund a clinical trial for its NGP phenotyping platform and is eligible for an additional $36 million.
IQuity develops tests that use RNA expression data to predict, detect, and monitor disease, as well as stratify patients by severity of disease.
The grants include funding for five new clinical sites, a new metabolomics core, and increased model organism capabilities.
The goal of the project is to develop a strategy that will increase demand for and access to HIV self-testing among at-risk Nigerian youths.
The researchers will conduct clinical validation in children suspected of having been exposed to high levels of manganese in Chicago.
Of the 1,194 Horizon 2020 proposals received between 2014 and 2017, most were related to the development of IVDs, while a third were focused on personalized medicine.
The Israeli firm recently announced the results of a multicenter study of its Bladder EpiCheck test in addition to netting €2.5 million in EU funding to develop a lung cancer assay.
Several companies will receive grants to develop hepatitis C molecular point-of-care and core antigen diagnostic assays.
The firm aims to have its test on the European clinical market by early next year, followed by a launch in the US.
The firm will use the grant to expedite the development of tests to identify more than 25 bacterial pathogens and antibiotic resistance markers in whole blood samples.